Q. Wang

7.5k total citations · 2 hit papers
62 papers, 3.0k citations indexed

About

Q. Wang is a scholar working on Molecular Biology, Oncology and Electrical and Electronic Engineering. According to data from OpenAlex, Q. Wang has authored 62 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 17 papers in Oncology and 12 papers in Electrical and Electronic Engineering. Recurrent topics in Q. Wang's work include Advanced Battery Materials and Technologies (12 papers), Advancements in Battery Materials (12 papers) and Lung Cancer Research Studies (11 papers). Q. Wang is often cited by papers focused on Advanced Battery Materials and Technologies (12 papers), Advancements in Battery Materials (12 papers) and Lung Cancer Research Studies (11 papers). Q. Wang collaborates with scholars based in China, United States and United Kingdom. Q. Wang's co-authors include Wei Xie, Li‐Zhen Fan, Wei‐Li Song, Zhenhai Du, Tin Chiu Li, Rachel Cutting, Hassan Sallam, William J. Ledger, Fenghua Liu and Kee Ong and has published in prestigious journals such as Nature, Nature Genetics and Molecular Cell.

In The Last Decade

Q. Wang

59 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recurrent implantation failure: definition and management

2013 611 citations Q. Wang et al. profile →
Allelic reprogramming of 3D chromatin architecture during early mammalian development

2017 366 citations Q. Wang, Yuanyuan Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Q. Wang China	26	1.5k	608	504	488	365	62	3.0k
Toru Suzuki Japan	23	938 0.6×	145 0.2×	240 0.5×	91 0.2×	69 0.2×	82	1.7k
Zhen‐Ao Zhao China	25	1.7k 1.1×	409 0.7×	223 0.4×	249 0.5×	14 0.0×	58	2.6k
Abbas Piryaei Iran	29	538 0.3×	145 0.2×	409 0.8×	494 1.0×	11 0.0×	118	2.4k
Jae Ho Lee South Korea	24	1.9k 1.2×	122 0.2×	783 1.6×	778 1.6×	11 0.0×	67	3.0k
L. M. Popescu Romania	27	931 0.6×	193 0.3×	94 0.2×	127 0.3×	47 0.1×	66	2.0k
Hexige Saiyin China	28	1.2k 0.8×	170 0.3×	114 0.2×	100 0.2×	143 0.4×	82	2.1k
Milena Králíčková Czechia	24	387 0.3×	373 0.6×	249 0.5×	624 1.3×	19 0.1×	103	1.9k
Cinzia Marchese Italy	30	1.3k 0.9×	227 0.4×	166 0.3×	57 0.1×	19 0.1×	100	2.7k
Yu Kang China	19	534 0.3×	151 0.2×	51 0.1×	135 0.3×	54 0.1×	72	1.2k

Countries citing papers authored by Q. Wang

Since Specialization

Citations

This map shows the geographic impact of Q. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Q. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Q. Wang more than expected).

Fields of papers citing papers by Q. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Q. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Q. Wang. The network helps show where Q. Wang may publish in the future.

Co-authorship network of co-authors of Q. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Q. Wang. A scholar is included among the top collaborators of Q. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Q. Wang. Q. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Di, Qujiang Sun, Q. Wang, et al.. (2025). Facilitating Na-ion transport and enhancing energy density of Na3V2(PO4)3 through Na3V3(PO4)4/Na3V2(PO4)3 heterostructure design. Chemical Engineering Journal. 510. 161691–161691. 1 indexed citations

Wu, Ziyu, Fei Yuan, Siyu Wu, et al.. (2025). Carbonyls Mediated Dual‐Function Enables High‐Performance Carbon Anodes in Ester‐based Electrolyte. Advanced Science. 12(34). e03954–e03954.

Wang, Q., Pin Zhang, Di Zhang, et al.. (2022). A two-step strategy for constructing stable gel polymer electrolyte interfaces for long-life cycle lithium metal batteries. Journal of Materiomics. 8(5). 1048–1057. 12 indexed citations

Wu, Yi‐Long, et al.. (2022). 85P Adjuvant osimertinib in patients (pts) with stage IB–IIIA EGFR mutation-positive (EGFRm) NSCLC after complete tumour resection: ADAURA China subgroup analysis. Annals of Oncology. 33. S73–S73. 3 indexed citations

Zhou, Chi, Ximing Xu, G. Chen, et al.. (2022). 3MO First-line camrelizumab plus carboplatin and paclitaxel for advanced squamous non-small cell lung cancer: Updated overall survival results from the phase III CameL-sq trial. Annals of Oncology. 33. S28–S28. 5 indexed citations

Xu, Chong‐Rui, Chengzhi Zhou, Lin Wu, et al.. (2021). 98P Camrelizumab as neoadjuvant, first- or later-line treatment for non-small cell lung cancer (NSCLC): A retrospective real-world study (CTONG2004). Annals of Oncology. 32. S1417–S1417. 1 indexed citations

Wang, Yufeng, et al.. (2021). 69P Combining sintilimab with anlotinib as second-line or later therapy in patients with extensive-disease small cell lung cancer: A prospective, single-arm, phase II trial. Annals of Oncology. 32. S1402–S1402. 2 indexed citations

Wang, Q., Guang Yu, Ming Xuan, et al.. (2020). Imprecise DNMT1 activity coupled with neighbor-guided correction enables robust yet flexible epigenetic inheritance. Nature Genetics. 52(8). 828–839. 74 indexed citations

Liu, Yao-Bin, Ying Cheng, Q. Wang, et al.. (2020). 1787P Effect of anlotinib in advanced small cell lung cancer patients with pleural metastases/pleural effusion: A subgroup analysis from a randomized, double-blind phase II trial (ALTER1202). Annals of Oncology. 31. S1036–S1036. 3 indexed citations

10.

Cheng, Ying, Q. Wang, K. Li, et al.. (2019). P2.12-26 The Impact of Anlotinib for Relapsed SCLC Patients with Brain Metastases: A Subgroup Analysis of ALTER 1202. Journal of Thoracic Oncology. 14(10). S823–S824. 7 indexed citations

11.

Wang, Q., Ying Cheng, K. Li, et al.. (2019). OA03.02 Effect of Anlotinib in Advanced Small Cell Lung Cancer Patients Previously Received Chemoradiotherapy: A Subgroup Analysis in ALTER 1202 Trial. Journal of Thoracic Oncology. 14(10). S211–S211. 3 indexed citations

12.

Li, K., Ying Cheng, Q. Wang, et al.. (2019). P2.12-11 Quality of Life in ALTER1202 Trial of Anlotinib as Third-or Further Line Therapy for Advanced Small Cell Lung Cancer (SCLC): A Post-Hoc Analysis. Journal of Thoracic Oncology. 14(10). S816–S816. 3 indexed citations

13.

Cheng, Ying, Q. Wang, K. Li, et al.. (2018). OA13.03 Anlotinib as Third-Line or Further-Line Treatment in Relapsed SCLC: A Multicentre, Randomized, Double-Blind Phase 2 Trial. Journal of Thoracic Oncology. 13(10). S351–S352. 47 indexed citations

14.

Wang, Qi, Shan Zhang, Tingting Liu, et al.. (2018). Sarm1/Myd88-5 Regulates Neuronal Intrinsic Immune Response to Traumatic Axonal Injuries. Cell Reports. 23(3). 716–724. 60 indexed citations

15.

Chen, L., et al.. (2018). 1177 CCN1/Cyr61 stimulates melanogenesis through integrin α6β1, p38 MAPK and ERK1/2 signaling pathways in normal human epidermal melanocytes (NHEMs). Journal of Investigative Dermatology. 138(5). S200–S200. 1 indexed citations

16.

Zhang, Wenhao, Weikun Xia, Q. Wang, et al.. (2016). Isoform Switch of TET1 Regulates DNA Demethylation and Mouse Development. Molecular Cell. 64(6). 1062–1073. 78 indexed citations

17.

Meng, Songyan, et al.. (2016). Inhibition of MicroRNA-383 Ameliorates Injury After Focal Cerebral Ischemia via Targeting PPARγ. Cellular Physiology and Biochemistry. 39(4). 1339–1346. 24 indexed citations

18.

Guo, Weigang, Q. Wang, Lin Xu, et al.. (2011). Diazoxide Decreases Ischemia-Reperfusion Injury in a Rat Model of Lung Transplantation. Transplantation Proceedings. 43(7). 2510–2516. 7 indexed citations

19.

Cao, Peng, et al.. (2011). Quantitative determination of allele frequency in pooled DNA by using sequencing method. Journal of Chromatography B. 879(7-8). 527–532. 6 indexed citations

20.

Han, Fei, Wenbo Xiao, Ying Xu, et al.. (2008). The significance of BOLD MRI in differentiation between renal transplant rejection and acute tubular necrosis. Nephrology Dialysis Transplantation. 23(8). 2666–2672. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact